Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Rodrigo Alonso MD, PhD

Rodrigo Alonso MD, PhD

Co-Director, Center for Advanced Metabolic Medicine and Nutrition; Assistant Professor, Faculty of Medicine, University Finnis Terrae, Santiago, Chile

Rodrigo Alonso, MD, PhD, achieved Specialist in Internal Medicine from Universidad de Valparaiso, Chile. He received his PhD in Medicine and Magister in Clinical Nutrition from Universidad Autónoma de Madrid, Spain.

He is Co-Director Center for Advanced Metabolic Medicine and Nutrition in Santiago de Chile, where he carries out his clinical work. Since 2016, Dr Alonso is President of the Chilean Atherosclerosis Working Group Corporation.

From 1997 until June 2014, Dr Alonso worked at the Lipid Clinic, Internal Medicine Department at Fundación Jiménez Díaz, Madrid, Spain.

From 2014 to February 2020, Dr Alonso worked as staff in the Department of Nutrition at Clínica Las Condes, Santiago de Chile. He was Head of the Department from 2016 to January 2020. During this period, he was the coordinator of the local registry for patients with Familial Hypercholesterolemia.

Dr Alonso was a Co-founder of the Spanish Familial Hypercholesterolemia Foundation, and currently he is member of the Scientific Committee. Until 2014, he coordinated the Spanish Follow-up Study of Families with Familial Hypercholesterolemia (SAFEHEART). He is the National Leader for the European Atherosclerosis Society  FH Study Collaboration.

Dr. Alonso is Member at large of the International Atherosclerosis Society Board and member of the board and Treasurer of the Association of the Iberoamerican Familial Hypercholesterolemia Network. Recently elected as Chair for the Federation of the Americas, International Atherosclerosis Society.

Since 2020, Dr. Alonso has been Assistant Professor at the Faculty of Medicine, Finis Terrae University, Santiago de Chile.

Disclosures

Dr. Alonso reports the following: honorary fees as a speaker and for participation in advisory boards from Abbott, Amgen, Boehringer-Ingelheim, PTC Therapeutics, Tecnofarma, and Saval.

Recent Contributions to PracticeUpdate:

  1. Prevalence of Statin Intolerance